Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!
暂无分享,去创建一个
M. Ilyas | P. Kaye | G. Cross | W. Fadhil | Joanne Field
[1] J. Hurley,et al. The molecular genetics of colorectal cancer , 2013, Frontline Gastroenterology.
[2] M. Ilyas,et al. Immunostaining for mismatch repair (MMR) protein expression in colorectal cancer is better and easier to interpret when performed on diagnostic biopsies , 2012, Histopathology.
[3] A. Guarné,et al. Nuclear import of human MLH1, PMS2, and MutLα: Redundancy is the key , 2009, Molecular carcinogenesis.
[4] J. Shia. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. , 2008, The Journal of molecular diagnostics : JMD.
[5] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[6] A. Duval,et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.